Barriers to Pregnancy Spacing in Women Living with HIV: A Series of Informational Interviews by Scott, Rachel K et al.
The Qualitative Report
Volume 23 | Number 5 Article 3
5-7-2018
Barriers to Pregnancy Spacing in Women Living
with HIV: A Series of Informational Interviews
Rachel K. Scott
MedStar Health Research Institute and Department of Women’s and Infants’ Services, MedStar Washington Hospital Center,
rachelkscott@gmail.com
Piyapa Praditpan
NYU Langone Medical Center, NYU School of Medicine, New York, New York, USA, piyapa.praditpan@nyumc.org
Patricia Tanjutco
MedStar Health Research Institute
Elizabeth Laidlaw
George Washington University
Regina Zopf
George Washington University
See next page for additional authors
Follow this and additional works at: https://nsuworks.nova.edu/tqr
Part of the Community Health and Preventive Medicine Commons, Female Urogenital Diseases
and Pregnancy Complications Commons, Immune System Diseases Commons, Quantitative,
Qualitative, Comparative, and Historical Methodologies Commons, and the Women's Health
Commons
This Article is brought to you for free and open access by the The Qualitative Report at NSUWorks. It has been accepted for inclusion in The
Qualitative Report by an authorized administrator of NSUWorks. For more information, please contact nsuworks@nova.edu.
Recommended APA Citation
Scott, R. K., Praditpan, P., Tanjutco, P., Laidlaw, E., Zopf, R., & Schladen, M. M. (2018). Barriers to Pregnancy Spacing in Women
Living with HIV: A Series of Informational Interviews. The Qualitative Report, 23(5), 1055-1074. Retrieved from
https://nsuworks.nova.edu/tqr/vol23/iss5/3
Barriers to Pregnancy Spacing in Women Living with HIV: A Series of
Informational Interviews
Abstract
For reproductive-age women living with HIV, birth spacing allows for optimization of maternal health and
viral suppression to prevent mother-to-child transmission of HIV. We conducted semi-structured
informational interviews to explore use of contraception for birth spacing. Interviews were transcribed and
analyzed. Audio files were reviewed to capture non-explicit data. We interviewed 18 multiparous HIV positive
women. All described experiences with at least one contraceptive method. Six themes emerged: Burden of
contraception, Failure of birth control, Impact of youth and lack of life experience, Community beliefs about
birth control, Lack of partner cooperation, and Altruism. Women viewed birth spacing favorably. Young age at
first delivery, contraceptive side effects, non-adherence to short-acting methods, lack of partner cooperation,
and prior contraceptive failure were identified as barriers to ideal birth spacing. Additional outreach is needed
in women living with HIV to overcome barriers to planned pregnancy and birth spacing.
Keywords
HIV; Pregnancy Spacing; Birth Spacing; Inter-Pregnancy Interval; Dual Method; Contraception; Family
Planning; Miles, Huberman and Saldaña Analytic Framework
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
Acknowledgements
This study was supported by funding from the MedStar Washington Hospital Center Graduate Medical
Education.
Authors
Rachel K. Scott, Piyapa Praditpan, Patricia Tanjutco, Elizabeth Laidlaw, Regina Zopf, and Manon M. Schladen
This article is available in The Qualitative Report: https://nsuworks.nova.edu/tqr/vol23/iss5/3
The Qualitative Report 2018 Volume 23, Number 5, Article 2, 1055-1074 
   
Barriers to Pregnancy Spacing in Women Living with HIV:  
A Series of Informational Interviews 
 
Rachel K. Scott 
MedStar Health Research Institute, Hyattsville, Maryland, USA 
MedStar Washington Hospital Center, Washington DC, USA 
 
Piyapa Praditpan 
NYU Langone Medical Center, NYU School of Medicine, New York, New York, USA 
 
Patricia Tanjutco 
MedStar Health Resaerch Institute, Hyattsville, Maryland, USA 
 
Elizabeth Laidlaw and Regina Zopf 
George Washington University, Washington DC, USA 
 
Manon M. Schladen 
MedStar Health Research Institute, Hyattsville, Maryland, USA 
Georgetown University Medical Center, Washington DC, USA 
 
For reproductive-age women living with HIV, birth spacing allows for 
optimization of maternal health and viral suppression to prevent mother-to-
child transmission of HIV. We conducted semi-structured informational 
interviews to explore use of contraception for birth spacing. Interviews were 
transcribed and analyzed. Audio files were reviewed to capture non-explicit 
data. We interviewed 18 multiparous HIV positive women. All described 
experiences with at least one contraceptive method. Six themes emerged: 
Burden of contraception, Failure of birth control, Impact of youth and lack of 
life experience, Community beliefs about birth control, Lack of partner 
cooperation, and Altruism. Women viewed birth spacing favorably. Young age 
at first delivery, contraceptive side effects, non-adherence to short-acting 
methods, lack of partner cooperation, and prior contraceptive failure were 
identified as barriers to ideal birth spacing. Additional outreach is needed in 
women living with HIV to overcome barriers to planned pregnancy and birth 
spacing. Keywords: HIV; Pregnancy Spacing; Birth Spacing; Inter-Pregnancy 
Interval; Dual Method; Contraception; Family Planning; Miles, Huberman and 
Saldaña Analytic Framework 
  
The optimal inter-pregnancy interval, the time lapse between birth of one child and 
subsequent conception, is at least 24 months (World Health Organization, 2005). Although 
much of the literature on pregnancy intervals is older, shorter inter-pregnancy intervals have 
been consistently associated with poorer maternal outcomes, including maternal obesity, 
gestational diabetes, preterm labor, increased risk of hemorrhage and anemia, and adverse 
neonatal outcomes, including low birth weight and cerebral palsy (Cleland, Conde-Agudelo, 
Peterson, Ross, & Tsui 2012; Conde-Agudelo & Belizán, 2000; Hanley, Hutcheon, 
Kinniburgh, & Lee, 2017; World Health Organization, 2005; Zhu, 2005). For women living 
with human immunodeficiency virus (HIV), pregnancy planning yields the additional and vital 
benefit of optimizing maternal health and prevention of mother-to-child transmission of HIV 
(Chersich et al., 2006; Wilcher & Cates, 2009). There is a dearth of literature on birth spacing 
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in women living with HIV in the developed world. In this study, we conducted interviews with 
inner-city multiparous women living with HIV to identify barriers and facilitators to 
maintaining ideal inter-pregnancy intervals and to explore women’s attitudes towards and 
experiences with dual method contraception. 
 
Literature Review 
 
Women who plan their pregnancies are more likely to remain adherent to medical 
treatment for HIV during the inter-pregnancy interval, resulting in suppressed maternal HIV 
viral load (the detectable level of the HIV virus in the maternal blood) and significantly 
decreased risk of mother-to-child-transmission of HIV (Raifman et al., 2014). In the United 
States (US), however, only one in six HIV positive women at risk of pregnancy reports current 
use of long-acting reversible contraception, such as an intra-uterine device or progesterone 
implant, which have been shown to be the most effective methods of unplanned pregnancy 
prevention (Sun et al., 2012). The rate of unintended pregnancy in Washington, D.C. (DC) is 
similar to the high national rate (58 v. 54 per 1,000 women aged 15 – 44; Kost, 2013). Rates 
of unplanned pregnancy and birth in HIV positive women are high but tend to reflect local rates 
in the uninfected population (Massad et al., 2004; Sutton, Patel, & Frazier, 2014). The rate of 
unplanned births to African American women living below the federal poverty limit is six-
times higher than of women with higher incomes, and twice that of non-Hispanic White women 
(Finer & Zolna, 2014).  
For people living with HIV seeking to avoid pregnancy, the World Health Organization 
recommends dual method contraception—namely use of condoms to reduce the risks of HIV 
and STI transmission along with an additional more effective birth control method to prevent 
unwanted pregnancy (World Health Organization, 2015). Despite this recommendation, the 
majority of women living with HIV in the US who do not seek pregnancy do not practice dual 
method contraception (Massad et al., 2007; Wilson, Koenig, Walter, Fernandez, & Ethier, 
2003), leaving them at risk for unplanned pregnancy and/or transmission of HIV and STIs. 
Few investigators have explored trends in dual method contraceptive attitudes and 
behaviors among these HIV positive women. Most recently, Haddad and colleagues used a 
large US healthcare claims database to describe trends in prescription-based contraceptive use 
in HIV positive women (Haddad et al., 2017). Of the 1,185 women they identified, only 28.9% 
were linked to claims for prescription-based contraception, including short- or long-acting 
reversible contraceptives and female sterilization. The remainder and majority could not be 
linked to claims for these methods, which are the types most often used in addition to condoms. 
Massad and colleagues (2007) analyzed 2,784 structured interviews conducted as part of a 
multi-center prospective cohort study of women living with HIV, in order to describe trends in 
contraceptive use. They found that over an 11-year period, HIV positive women chose 
condoms (30.5 – 36.3%), followed by tubal ligation (21.8 – 26.5%), and then hormonal 
contraceptives (<10%) as their preferred mode of birth control; the rate of intrauterine device 
use remained steady at less than 5% per year (13). Wilson and colleagues (2003) interviewed 
258 HIV positive women at 6-months postpartum to assess their attitudes and behaviors 
towards dual use contraception; among women who reported at least one act of sexual 
intercourse since childbirth, 86.6% reported condom use. They found that only 57.4% of HIV 
positive women reported use of either female sterilization or hormonal contraceptives. When 
Wilson compared women who were consistent dual users with inconsistent dual users, they 
found that women in the former group were more highly motivated to avoid rapid repeat 
pregnancy (OR 2.4, 95% CI 1.05 – 5.37). Chen, Phillips, Kanouse, Collins, and Miu (2001) 
found that HIV positive women’s fertility desires and attitudes towards pregnancy can be 
incongruous; 69% of the HIV positive women interviewed did not desire children in the future, 
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however despite certainty in not wanting additional children, 27% would not choose to 
terminate an unintended pregnancy. 
Barriers and facilitators to birth spacing and dual contraception use among women 
living with HIV in resource rich countries, such as the US, are poorly understood. Medical 
providers must know the determinants of successful birth spacing and contraception use if they 
are to facilitate planned pregnancy and reduce mother-to-child-transmission of HIV. The goal 
of our study is to address this knowledge gap and to better understand HIV positive women’s 
experiences with birth spacing and dual contraception.  
The study was designed by Drs. Rachel Scott (R. S.) MD, MPH and Regina Zopf (R. 
Z.) MD, obstetrician-gynecologists who provide prenatal and gynecologic care for women 
living with HIV at an urban hospital in DC. Our research was born out of the desire of Drs. 
Scott and Zopf to better understand the high rates of short-interval unintended pregnancy in 
their HIV positive patient population. Patricia Tanjutco (P. T.) MD, a research coordinator with 
several years’ experience working with women living with HIV, recruited patients from Drs. 
Scott and Zopf’s clinic and conducted the patient interviews. Piyapa Praditpan (P. P.) MD, an 
obstetrician-gynecology resident, and Elizabeth Laidlaw (E. L.), a Masters of Public Health – 
Physician’s Assistant student, facilitated interviews and assisted with data analysis as part of 
their medical research training. R. S. and R. Z. did not participate in interviews secondary to 
concern that it would bias participants’ responses. Manon Schladen (M. S.) PhD, a qualitative 
researcher working primarily with individuals from underserved, urban African-American 
communities, consulted on study methodology and served as the primary qualitative analyst. 
Dr. Schladen’s research focus over the past several years has been on crystalizing the patient 
perspective to support health care that is increasingly patient-centered. The only non-clinician 
on the study, Dr. Schladen brought the personal perspective of a multiparous woman with 
equivocal experiences of contraception and birth spacing to provide counterpoint to the 
research team. 
 
Research Question 
 
What are the barriers and facilitators of optimal birth spacing and dual contraception 
use among underserved, urban women living with HIV in the United States? 
 
Methods 
 
Approval 
 
This study received approval from the institutional review board for the medical center 
where it took place. 
 
Recruitment and Participants 
 
For this study, we sought a convenience sample of patients who received outpatient 
obstetric and/or gynecologic care at the major urban hospital in DC where R. S. and R. Z. are 
in practice. Women who receive care at this institution are largely representative of our 
population of interest: inner city, African American, and living below the federal poverty level. 
Study personnel (R. S., P. T., E. L.) identified and recruited female patients living with HIV. 
P. T. and E. L. reviewed patients’ demographic and medical information in the electronic 
medical record to screen for eligibility. We included women who were of reproductive age (18 
– 45 years), multiparous, HIV positive, and English-speaking. Patients meeting the inclusion 
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criteria fell into two categories of interest: (1) those with inter-pregnancy intervals greater than 
two years apart and (2) those with inter-pregnancy intervals less than two years apart. 
 
Semi-Structured Interviews 
 
After written informed consent was obtained, women participated in face-to-face, 
individual or paired, semi-structured interviews (conducted and audio-recorded by P. T.). A 
professional transcription service provided electronic transcripts the interview audio. We 
designed interviews to take place within a 30-minute time window to make it feasible for our 
patients to participate before or after their scheduled clinic appointments. The study team 
conceived this approach to reduce potential burden on participants, for whom transportation 
and family issues often create barriers to coming to the clinic. Women received a $50 gift card 
and transportation reimbursement in appreciation of their participation. Interview questions 
focused on women’s use of short-acting and long-acting reversible contraceptives and barriers 
and facilitators of birth spacing. Beyond the initial screening done to establish eligibility, we 
did not compare participants’ descriptions of their experiences with contraception or pregnancy 
spacing to what may have been recorded in their medical records. Our intent was to give 
primacy to how participants experienced and made sense of those phenomena. 
 
Analytic Framework and Process 
 
We adopted the broadly applicable framework described by Miles, Huberman, and 
Saldaña (2014) to analyze participants’ interviews. The framework defines three major phases 
of data analysis: data reduction, data display, and conclusion drawing and verification. Data 
reduction is the iterative process of selecting and focusing data in relation to one’s research 
questions. Data display may be graphical or text-based, but its essence is organization and 
compression, characteristics that promote visualization of emerging themes and relationships. 
Conclusion drawing and verification is the culmination of the research process and the phase 
where the researcher interprets and ascribes meaning to the analyzed data.  
The primary qualitative analyst (M. S.) used NVivo (version 10, qualitative data 
analysis software; QSR International Pty Ltd, Docaster, VIC, Australia) (QRS International, 
2015) to reduce the data, which consisted of participants’ interview audio files and transcripts. 
She memoed the transcripts while listening to the audio of the interviews both as a verification 
step and to capture non-explicit data (e.g., hesitation, tone of voice). Where she was in doubt 
as to what was said or meant, M. S. consulted with the research team member(s) who had 
conducted the interview in question. She first coded each transcript to the interview questions, 
which were developed a priori and did not vary across interviews. M. S. subsequently engaged 
in a continual, reflective process of iterative memoing, theme identification and exploration. 
She kept a research journal to track how her understanding evolved over time as she 
increasingly immersed herself in the interview data. Maintaining a reflective journal 
throughout a study exposes the degree to which the researcher is able to bracket (Tufford & 
Newman, 2010), transcend his/her personal biases, in qualitative analysis. Journaling is a best 
practice that introduces transparency into the research process and enhances confirmability 
(Trochim & Donnelly, 2008) and credibility (Morse, Barrett, Mayan, Olson, & Spiers, 2002) 
of findings. Further, the process of making sense of qualitative data as it emerges is essential 
to its coherence (Morse et al., 2002; Reigeluth & Frick, 1999). Because emergence is non-
linear, Morse et al. (2002) advocate a specific aim (reminiscent of quantitative approaches) of 
“methodological coherence” in study designs. The function of methodological coherence is to 
continually bring the researcher back to the question or questions guiding the study to promote 
recognition that how the emerging data is taking shape may require revisiting earlier coded 
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passages and exploring them in a new light. To promote methodological coherence, M. S. 
adopted a deliberate practice of reflecting on whether each subsequent interview cast previous 
ones in a different light and committing her thoughts to the journal.  
M. S. developed a classification scheme based on themes and participant characteristics 
to delineate the similarities and differences in participants’ experience of child spacing and 
adherence to the dual method of birth control prescribed for persons who are HIV positive. The 
scheme gave rise to the development of a series of displays to help visualize themes and trends 
in women’s experience with dual method contraception and birth spacing.  
The clinical research team (R. S., P. P., P. T., E. L.) reviewed the displays to verify, 
question, or further explore the experiences and perceptions that M. S. saw in the data. After 
discussion, M. S. used a trace-back approach to provide greater about which themes adhered 
to which participants and to aid in drawing conclusions, the final step of the Miles, Huberman, 
and Saldaña framework (2014). To protect their privacy, we assigned pseudonyms to all 
women interviewed in the study and reviewed the data presented to assure that there was not 
sufficient information provided about any individual to allow recognition. We did not create 
composite profiles as we believed that the characteristics presented in each woman’s history 
were relevant in understanding her experience of using dual method birth control and spacing 
her children and contrasting it with that of other participants. 
 
Results 
 
Organization of Results 
 
In presenting our results, we first provide an in-depth description of the women who 
participated in interviews to familiarize the reader with the range of participants’ experiences 
with pregnancy spacing and dual method contraception after HIV infection. We delineate 
which women spaced their pregnancies at the prescribed interval and which had not done so to 
point up individual differences in women’s experience that may help explain adherence and 
non-adherence to recommended practices. Finally, we explore the major and minor themes that 
emerged from interviews and which may help better understand the barriers and facilitators to 
dual method contraception use and pregnancy spacing in underserved, urban women who are 
HIV positive. 
 
Interview Cohort Descriptive Statistics 
 
Eighteen, HIV positive women participated in this study. Participants’ motherhood 
experience ranged from four to 25 years. Cumulatively, they reported 65 children (Table 1). 
Seven women were pregnant at the time of their interview. Their unborn children were included 
in the total number of children (twins counted only once). Women reported birth-spacing 
history in years, thus we used a conservative approach to differentiate between pregnancies 
spaced at less than or greater than two-year (24-month) intervals. Unless specified, we counted 
participants’ children as spaced less than two years apart if their difference in ages was reported 
as two years. Women reported 13 pregnancies spaced ≤2 years apart and 34 pregnancies spaced 
>2 years apart. 
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Table 1. Descriptive Statistics on Participants (Self-report) 
Total Number of Women Responding 18 
Total Number of Living Children1 and Current 
Pregnancies (twins counted once) 
65 
Range in Years of Motherhood 4 – 25 
Total Inter-pregnancy intervals > 2-years 34 
Total Inter-pregnancy intervals <= 2-years 13 
Pregnant at Time of Interview 7 
Child Spacing as Result of Not Being in a 
Relationship or Stated Periodic Abstinence 
4 
Married Status Rationale for Choices 2 
Attributed a Child (Unplanned) to Not Using 
Birth Control 
8 
Experience with Long-term Birth Control Methods 
Oral Contraceptive Pills (OCPs) 132 
Depot medroxyprogesterone acetate (DMPA) 
“Depo Provera” 
15 
Intrauterine device (IUD) 63 
Implant 14 
Patch 6 
Ring 25 
Tubal Ligation 36 
Hysterectomy 17 
Other 18 
Experience with Condoms 
Male Condoms 17 
Female Condoms 1 
 
These 18 HIV positive women fell into two, basic patterns of child spacing: Pattern A  
≤2 years spacing for a woman’s older children, but >2 years spacing between her younger 
children; Pattern B consistent spacing of children >2 years apart (Table 2) 
 
Patterns 
A B 
≤-year spacing with older children, 
>2-year spacing with younger 
children 
 
Consistent >2-year spacing 
through reproductive years 
 
Women 
Althea, Collette, Eve, Georgia, 
Helen*, Joanne, Karen, Olivia, Quiana 
Bethany, Denise, Flo, Isabelle, Lisa, 
Marie, Noreen, Polly, Regina 
 *Consistent child spacing of ≤2 years  
                                                          
1 Some women alluded to perinatal deaths of children and having miscarriages but they did not elaborate on then. 
These children/pregnancies are, therefore, not part of this tally unless the woman specifically included them in 
her description of child spacing. 
2 One additional woman considering OCPs 
3 Two additional women considering IUDs 
4 One additional woman considering an Implant 
5 One additional woman considering the ring 
6 Two additional women planning tubal ligations after delivery of current pregnancy 
7 Not intended as birth control, performed due to complications after delivery 
8 Lunelle (information volunteered) 
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All women reported some experience with a birth control method. The majority (11) 
reported prior use of two reversible methods of contraception. Four women reported experience 
with three of these methods and two women reported use of four. All but one woman reported 
experience with male condoms; one participant reported experience with female condoms. Of 
hormonal contraceptives, most women (13) reported experience with Depo-Provera (depot 
medroxyprogesterone acetate) followed by oral contraceptive pills. Less than half of women 
(6) reported experience with the contraceptive patch and a couple reported experience with the 
contraceptive ring. Less than half of the participants reported use of a long-acting reversible 
contraceptive method; six had used an intrauterine device and one had used a progesterone 
implant. Three women were using tubal ligation as contraception, while two others planned to 
undergo this procedure after delivery of their current pregnancies.  
 
Identified Themes 
 
Five major and three minor themes emerged from analysis of women’s interviews. The 
themes in this study are attitudes, experiences, or perceptions that have influenced more than 
one woman’s actions with respect to using dual method contraception and spacing of 
pregnancy. 
 
Theme 1: Incomplete understanding of rationale behind recommendations for 
pregnancy spacing and use of dual method birth control when HIV positive. 
 
Women provided highly variable responses when asked what they considered to be the 
“ideal” interval for pregnancy spacing after HIV (see figure 1). No woman recommended an 
interval shorter than the recommended 24 months, but neither did any woman identify 
prevention of mother-to-child transmission of HIV as a factor important in her decision-making 
relative to pregnancy spacing. Maternal well-being was identified, but not with reference to the 
special needs of maintaining health after HIV infection. Though all participants were living 
with HIV, they uniformly re-focused the question, and provided reasons for child spacing that 
might apply to women generally, rather than on the special health requirements relevant to HIV 
positive women.  
 
 
Figure 1. Participants’ assignment of ideal pregnancy spacing intervals 
 
0
1
2
3
Years between pregnancies
"Ideal" Pregnancy Spacing Intervals
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Isabelle’s responses, with respect to her second and third pregnancies, may be 
illustrative. Her focus is on issues of finances and independence from her family, not on the 
risks inherent in her HIV-positive status. 
 
Interviewer: What do you think is a good number of years to wait between 
children? 
Isabelle: In my opinion, I spaced my children. I had my 10-year-old when I just 
turned 21. I was not really financially ready, I was still living at home with my 
mom, and I waited until I got on my own to have my 3-year-old and I waited 
again to have this baby… 
Interviewer: So, what do you think is a good number of years to wait? 
Isabelle: The space that I did, the 10 and 3. 
 
Though they did not include the reference to personal practice “that I did” that Isabelle did, 
most women endorsed the spacing of their own children as ideal. Women’s lack of focus on 
the urgency of pregnancy spacing for prevention of mother-to-child-transmission of HIV may 
be rooted in an overall sense of resentment, not wanting to be reminded of their HIV-positive 
status that Flo expressed in a different context, noting that having to use condoms with one’s 
husband was just a continual reminder of living under the specter of HIV. 
We asked women who had longer inter-pregnancy intervals to describe what helped 
them wait between pregnancies. Again, participants responded with reasons not related to their 
HIV status. Rather than explaining the motivators and facilitators of birth spacing they 
experienced as HIV positive women, they noted maternal physical recovery and the difficulty 
of parenting many young children as motivators for child spacing. The follow two quotes are 
typical. 
 
Quiana: I say: you have to give your body basically a rest. You cannot keep 
having babies. You are trying to mess you up. Every pregnancy is not the same.  
Lisa: The age span is, like, you don't want to have ‘em back to back because of 
the growing process. I done seen people have two babies, maybe three, in 
pampers. 
 
Four women further attributed longer spacing between their pregnancies to being out of a 
relationship or abstinence from sexual relations. Again, neither of these situations takes HIV 
into account. 
Of the 18 women interviewed, 13 reported that they were aware of the recommendation 
to practice “dual method” contraception after HIV. Three women were unaware of the meaning 
of this contraceptive strategy. When discussing the use of condoms with a long-acting 
reversible contraceptive, half of women stressed the importance of condoms for STI prevention 
while half stressed their importance as back up to long-acting reversible contraception. Only 
two women acknowledged condom use for both STI and pregnancy prevention. Regardless of 
their ability to articulate awareness of the term “dual method” contraception, nine of the 
participants described contraceptive practices consistent with this method, although half 
expressed reservations about its efficacy. 
Overall, understanding of the need to space pregnancies at 24 months or greater to 
protect one’s child from HIV transmission appeared to be lacking, though women articulated 
other, common sense reason for child spacing at that interval. Understanding of and 
commitment to dual method contraception was likewise weak to absent. Women showed a 
strong tendency to hold the special requirements of longer interval child spacing and use of 
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dual method contraception apart from their thinking about family planning in general, casting 
a veil of normalcy and personal choice over the patterns they reported.  
The following theme (2) deals with locus of control, personal differences in action that 
result from the perception of one’s power to act and make a change. These differences in 
individuals’ perspectives did not clearly emerge in women’s demonstration of understanding 
of the need for longer interval child spacing and use of dual method birth control after HIV. 
Nor did these differences appear to impact our participants’ “drive to normalcy” when 
questioned about ideal child spacing. 
 
Theme 2: Successful pregnancy spacing and locus of control. 
 
Individuals who exhibit a strong internal locus of control are likely to believe they have the 
capacity to achieve a desired health outcome (Wallston, Osborn, Wagner, & Hilker, 2011). 
Essentially, persons with a strong internal locus of control believe that they have control over 
what happens in their lives. Conversely, persons with a strong external locus of control believe 
that what happens to them is outside of their control. We observed that women whose child 
spacing history conformed to Pattern B, spacing of pregnancies >2 years apart, expressed more 
statements suggesting an internal locus of control than did Pattern A women, those with a 
history of pregnancies spaced ≤ two-year intervals. Regina and Flo, both Pattern B child 
spacers, provide examples of attitudes suggesting strong internal locus of control. 
 
Regina: I do not feel good with the shot (Depot medroxyprogesterone acetate), 
but I have to take it because I do not want to get pregnant. 
Flo: I am thinking I could have a child that is negative, which I do. BOTH of 
my kids are negative!  
  
Regina is able to sublimate her issues with the Depot medroxyprogesterone acetate shot 
because of her resolve to avoid pregnancy. She makes a decision and assumes control. 
Likewise, Flo, knowing that if she follows the recommended medical regimen, she can prevent 
HIV transmission to her children, resolves to follow the approved regimen. She presents the 
results of her resolve with pride: neither of her children have HIV. 
In contract, Georgia and Karen, Pattern A child spacers, evidence more passive 
perspectives. 
 
Georgia: Whatever God brings to you, it is a blessing. My children are a 
blessing. The sickness that I have is only God, baby, believe me, that is a 
blessing… 
Karen: Stuff just happens, things just happen between you and your male 
friend. 
 
Georgia takes whatever life brings to her, believing that it is as it should be. Karen, likewise, 
is comfortable with her belief that male-female relationships simply chart their own course. 
The four women quoted here stood out in their demonstration of the poles of external/internal 
locus of control in their descriptions of their experiences with HIV. Notably, other participants’ 
discourse presented more neutral perspectives. 
  
Theme 3: The burden of contraception in HIV positive women. 
 
The theme of the burdensomeness of contraception was ubiquitous across interviews. 
Burden was associated with both long-acting reversible contraceptives and condom use. 
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Women cited several known side effects of contraception as barriers to use. They are 
summarized in the display provided in Table 3. Women reported fewer undesired side effects 
with oral contraceptive pills than Depot medroxyprogesterone acetate injections. Two women, 
however, described a sense of being overwhelmed by the prospect of taking oral contraceptive 
pills in addition to their HIV medications. Of the six women who had used the patch, one 
participant associated patch use with a history of stroke. Another participant reported that her 
Intrauterine Device migrated outside of the uterus and required surgical removal.  
 
Table 3. Reported side-effects with long-acting reversible contraceptives methods 
 
Women 
who 
reported 
Method 
 
General 
malaise 
Weight 
gain 
Bloating Nausea/GI 
disturbance 
Headache Change in 
menstrua-
tion 
Pain Hair loss Other 
physical 
complaints 
Serious 
medical 
complica-
tions 
15 Depot 
medroxyp-
rogester-one 
acetate  
1 10 3   2 19 4   
13 Oral 
contracep-
tive pill 
   2 1 1   2  
6 Intra-uterine 
device 
     1 3 1  110 
6 Patch          111 
2 Ring      1     
1 Implant      1     
 
The potential impact of certain hormonal contraceptive side effects on women’s self-
image was also a barrier to use, specifically with short-acting reversible contraceptives, 
including oral contraceptive pills and Depot medroxyprogesterone acetate. Participants 
described fear of weight gain and hair loss as problems with consistent use of these methods. 
One participant shared the following: 
 
Althea: This is going to be kind of superficial to say, but a lot of the birth 
controls now tend to put a little extra weight on you and so for that reason, 
myself and a lot of other women do not want to use it. 
 
Althea identifies distaste for putting on extra weight as “superficial,” not equal to the greater 
good of optimal child spacing. At the same time, however, she reveals insult to a women’s self-
image as a potent disincentive to contraception use. 
                                                          
9 Pain at injection site 
10 Extrauterine migration necessitated surgical removal 
11 Informant reported stroke 
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Multiple women identified adherence to short-acting reversible contraceptives as a 
barrier to ideal pregnancy spacing. Nine women stated that adherence to daily dosing of oral 
contraceptive pills and routine maintenance of clinic appointments for Depot 
medroxyprogesterone acetate injections were barriers to successful use of these methods. Four 
women discussed the “intrusiveness” or “unnaturalness” of condoms as well as lack of 
cooperation from partners with use. One participant reported adherence to condom use, 
however described doing so as an undesired reminder of her HIV positive status. 
In summation, burden emerged as a multi-faceted theme from women’s interviews. It 
included long-acting reversible contraception side effects, those causing women to feel 
physically unwell and also those impacting their self-image, such as weight gain and hair loss. 
It also included distaste for the disruption of the natural flow of sexual relations due to required 
condom use and the continual reminder of one’s HIV positive status that condom use inflicted. 
 
Theme 4: Failure of birth control in women living with HIV. 
 
Our interviews yielded numerous definitions of “birth control failure.” Women who 
reported experience with hormonal short-acting reversible contraceptives defined failure as the 
experience of an unplanned pregnancy. Other women referred to Intrauterine Device migration 
and male condom breakage as method failure, whether or not these resulted in unplanned 
pregnancy.  
Women with both patterns A (children spaced at ≤2 years) and B (children spaced at 
>2 years), of child spacing experienced birth control failure. They reported failure to adhere to 
their chosen method as well as device failure. Four of the six women who had used Intrauterine 
Devices, reported device failure. Women who adopted Pattern B birth spacing reported 
experience with a greater variety of long-acting reversible contraceptive methods and twice the 
number of birth control failure descriptions as women who adopted Pattern A birth spacing 
(Table 4). Eight women explicitly attributed an unplanned pregnancy to not using birth control. 
 
Table 4. Self-reported failure12 of birth control methods  
RED= Pattern B; BLUE= Patterns A 
Method/ 
Reports 
Failure Reasonably 
Related to Method 
Failure Itself 
Failure Related to 
Improper Use 
Failure Mentioned, 
Circumstances Not 
Elaborated 
Depot 
medroxypro-
gesterone 
acetate (3) 
 
 ● Georgia: “I think that 
issue, because I had 
missed a month and I 
went back to go get the 
shot.” 
● Helen: “I was taking 
Depo for a second and 
then I stopped. It 
● Polly: “I was on … 
the shot and I got 
pregnant …” 
 
 
                                                          
12 “Failure,” when used in conjunction with methods more readily controlled by the woman, e.g., OCPs, Depo, 
the patch and the ring, signifies that an unplanned pregnancy occurred. In these cases, the woman’s indication that 
the method has failed is pregnancy. “Failure,” when used in conjunction with methods less likely to be under a 
woman’s direct manipulation, e.g., the IUD and male condoms, includes migration (IUD) and breakage (condom) 
with or without accompanying incidence of unplanned pregnancy. In these incidences, it is obvious that the 
method isn’t doing what it’s supposed to do without a pregnancy having to occur. 
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seemed like as soon as I 
stopped, I got pregnant.” 
Oral 
Contraceptive 
Pills (OCPs) 
(1) 
 
 ● Polly: “I just forgot 
…and I got pregnant.” 
 
Intrauterine 
Device (IUD) 
(4) 
 
● Bethany: “I had it for 
two years …I just got 
pregnant while I was 
on it.” 
● Collette: “Actually, 
after I had my daughter 
I tried a new form of 
birth control, which 
was the IUD. I got 
pregnant with the IUD 
still inserted with my 
son. I was in the low 
percentile of that 
possibility of 
happening.” 
● Eve: “The only 
problem I had was it 
fell out.” 
● Flo: “The Mirena, they 
had to surgically 
remove it because it 
came out of my uterus 
and wrapped around 
my intestine.” 
  
Patch (3)  ● Noreen: Same thing (as 
the NuvaRing, e.g., 
stopped using it due to 
confusion). 
● Karen: “(I) didn’t know 
it wasn’t working.” 
● Bethany: “I got 
pregnant with my 
oldest.” 
 
 
Ring (1) 
 
 ● Noreen: “That was my 
fault with the NuvaRing 
because I thought after I 
go off I was supposed to 
put it on, but I was 
supposed to wait exactly 
seven days then pull it, 
so I just stopped taking 
it.” 
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Condoms, 
Male (6) 
● Polly: “It broke, that is 
why I use two.” 
● Noreen: “It broke.” 
● Quiana: “No 
challenges, except for 
the breaking.” 
 
 
● Noreen: “The father felt 
a little bit happier about 
himself, got a bigger 
size than what he 
needed. It came off. 
That is how I got my 
little girl.” 
● Georgia: “I just hate 
that part when you just 
get it stuck in you.” 
● Regina: “No, I have 
had no problem with 
condoms. Well, yes 
one time my last 
baby's father. That is 
why I got pregnant.”  
 
The experience of birth control failure, both failure of the method/device itself and 
failure related to proper use, was reported by both women who spaced their children at >2 year 
intervals and those who did not. That long birth spacers explored more methods of birth control 
than did short spacers may be significant and related to a possible greater tendency toward 
internal locus of control. 
  
Theme 5: The impact of youth and lack of life experience. 
 
All of the participants cited youth and lack of life experience as barriers to ideal 
pregnancy spacing. Two women with Pattern A birth spacing cast their own, youthful failures 
in recommended child spacing in that light.  
 
Olivia: My oldest ones, with them I just got pregnant. With the first three kids 
I got pregnant, I was young. You know, at 21 I had three kids, so I was just 
humping. Honestly, that is the truth in that. … With the last two, it was different. 
Georgia: I was young. I was young when I had them. I was 18 and 19 when I 
had them.  
 
Both Olivia and Georgia attribute their inability to space their early pregnancies to youthful 
nescience. Interestingly, their later children were spaced at the recommended >2-year interval. 
Some women related the degree of parental guidance they received as youths to 
prevention of HIV infection and pregnancy planning. Isabelle lamented that her mother had 
provided her no guidance at all and she was left to learn from her sad experiences. 
 
Isabelle: As females, we have daughters and when they get of age, you should 
be talking to them. My mother didn't talk to me. I had to find out the hard way. 
 
Flo, likewise, endorsed parental involvement, even the intimidating engagement modeled by 
her mother. 
 
Flo: It was different for me because my mother, she kind of scared me too. She 
scared me half to death, so I did not have sex until I was 18, but she scared me 
half to death and everything. She would go into the doctor's office. I went right 
over there to the adolescent clinic, I had Dr. Smith (pseudonym) and she would 
ask her, “Make sure her hymen is still there.” My mother was just in the room 
and wanted to know. Even though I told her, "I am still a virgin, mom," she did 
not believe me. 
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Georgia, on the other hand, recognizes that there is only so much a parent can do given the 
freedom of choice that adolescents increasingly have. 
 
Georgia: Nowadays there are little girls of age, because I have a 16-year-old, 
and I can want for her all day to have some type of birth control, but she has to 
want to have it. In other words, if she says no, the doctor cannot give her 
something that she is refusing and I do not think that is fair, as a parent. …I 
mean, we can encourage, but today's society, these young girls they are running 
wild rapidly and some parents are not even paying attention to most children 
and that is pretty much how a lot of things are happening, but, like I said again, 
my daughter is 16. I went to (the hospital clinic). I wanted her to have the Depo. 
If she refuses it, I cannot go in the room with her, they cannot tell me if she has 
sex. I think that is very emotional for me because I am a mother with HIV. 
 
In the absence of parental guidance, women endorsed schools and health clinics as important 
surrogates. Generally, women agreed that teaching should occur in a realm of authority like the 
health clinic, school, or home. They also acknowledged that media played an important role in 
sexual and reproductive health education. 
 
Olivia: I always say it (education about sexuality) should start in your home, 
but I think it needs to be exposed more in schools and they really need to start 
it in elementary honestly. It is out of control. You would be surprised what these 
young girls ask, these questions and stuff they know at 12 and 13, and this is 
stuff that their parents do not know. 
Regina: Educate them more so they can pick (condoms) up, because some 
young girls do not like using them and they do not pick them up. … They are 
not educated at all about using condoms. They think that having sex is okay 
with that person without using a condom … I think educating them more when 
they come in the clinic and talking to them and letting them know it is good to 
use condoms, do not be ashamed to use condoms so you will not catch anything! 
 
Women identified youth and lack of guidance as a significant problem in responsible sexuality. 
Here, as in much participants’ narrative, the line blurs between generally responsible behavior 
and the stricter behaviors that are necessary after HIV infection. 
 
Theme 6 (Minor): Community beliefs about birth control. 
 
Participants expressed skepticism about the efficacy of birth control, regardless of 
adopted pattern of birth spacing. Lack of confidence in the efficacy of dual method birth control 
was rooted in a personal sense of its burden and sustained by peers’ anecdotes of birth control 
failure. 
 
Isabelle: I hate (dual method contraception). The condoms are for protection 
against HIV and other sexually transmitted diseases, which I agree. The birth 
control is just to stop the pregnancy, but birth control is not always accurate. 
Because I have heard some of my female friends say they got pregnant on their 
shot. They got pregnant on the IUD (Intrauterine Device). 
Polly: No … you end up pregnant just like, I know a young lady she got that 
thing up in her thing and she got that and got pregnant. 
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Community beliefs and experiences of birth control failure like those expressed in the peer 
anecdotes shared by Isabelle and Polly appear to significantly influence participants’ opinions 
of contraceptive efficacy and decision-making regarding their use. 
 
Theme 7 (Minor): Lack of partner cooperation with family planning in 
reproductive aged women living with HIV. 
 
In addition to youth and contraceptive failure, several women reported lack of partner 
cooperation as a barrier to family planning and pregnancy spacing. Several women reported 
that lack of cooperation with condom use from sexual partners is common. Quiana described 
intentional sabotage by former partners: 
 
Quiana: Sometimes they will put a hole in it or then wait until the last minute 
and tell you. 
Interviewer: Intentionally put a hole in it? 
Quiana: Yes, they will if you are not paying attention and watching them. They 
will put a little hole in it and whatever. That happened to me plenty of times. 
 
Isabelle recounts lack of cooperation as well, but with a somewhat different tone. 
 
Isabelle: You are going to put it on (a condom). If you don't put it on, you're 
not getting nothing. 
 
Quiana and Isabelle describe the same reluctance of their partners to use condoms. Their 
attitudes and responses are different, however. Quiana is the victim of deception whereas 
Isabelle enforces her rule about condom use. Interestingly, Quiana is a Pattern A child spacer 
and Isabelle, a Pattern B. In this case as in earlier cases, the Pattern B spacer shows stronger 
internal locus of control than does the Pattern A spacer. 
 
Theme 8 (Minor): Altruism and contraception in women living with HIV. 
 
Altruism, expressed as the desire to reduce the risk of partner and mother-to-child 
transmission of HIV barely emerged as a motivator for adherence to dual method 
contraception. It was present most palpably in Isabelle’s recounting of condom use with her 
partner. 
 
Isabelle: I use condoms now with my partner, even though I'm pregnant. There 
is still a slight chance he could still catch HIV, so we have been using condoms. 
… I feel that since I got infected with HIV seven years ago, before that I didn't 
care. I didn't give a man a choice to put on a condom, but now since I've been 
infected and since I've been more careful, I have a choice now.  
 
Isabelle recounts how her priorities have changed since she has been HIV positive. She didn’t 
offer her partners a condom before she was infected, but now, in consideration of his well-
being, she does. Consideration, altruism toward her partner, provides a motivation to adhere to 
condom use. 
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Discussion 
 
Although a recent large retrospective review called into question the causality of short 
interpregnancy intervals on several previously attributed adverse pregnancy outcomes, there 
do appear to be clear maternal and neonatal benefits to birth spacing (Hanley et al., 2017). For 
women living with HIV, the opportunity to optimize HIV status through planned pregnancy 
and ideal birth spacing can yield significant benefits to maternal and neonatal health (Chersich 
et al., 2006; Raifman et al., 2014; Wilcher & Cates, 2009). 
The vast majority of our study participants reported male condom use for protection 
against both unplanned pregnancy and HIV transmission. Even so, women’s narratives 
described the challenges of consistent condom use. Women cited unnaturalness, difficulties 
with partner cooperation, and anecdotes of condom failure (e.g., popping, slipping off) as 
factors impeding consistent use. Their narratives also conveyed a sense of fatalism regarding 
the inevitability of product malfunction and development of interpersonal tension.  
Though reports of both anecdotes and personal experience with condom failure were 
largely universal among interview participants, their decisions relative to adherence to condom 
use was not. Personal factors that may relate to individuals’ locus of control emerge from their 
narratives. This hypothesis is consistent with the findings of Wallston and colleagues, who 
demonstrated the validity of the construct of locus of control/self-efficacy as measured by the 
Perceived Medical Condition Self-Management Scale (PMCSMS) in HIV positive patients 
(Wallston et al., 2011). 
Our findings of low uptake of highly effective contraception among HIV positive 
women susceptible to rapid repeat high-risk pregnancy is consistent with Wilson and 
colleagues’ findings (2003) of relatively low utilization of hormonal contraception and 
sterilization. Similarly, the incongruity described by Chen et al. (2001) is also reflected in our 
small sample of HIV positive women. The theme of the burden of contraception permeates our 
participants’ experiences and may account for reduced condom use. Our participants’ 
narratives suggest belief in one’s ability to achieve a goal may be a critical component to 
consistent use of condoms with highly effective contraceptives. We observed that strong 
feelings accompany fertility, childrearing, relationships with life partners and sexual partners, 
and HIV positive status. Women from our small sample underscore the need for personalized 
counseling regarding contraception and family planning. 
Pregnancy spacing and prevention of HIV transmission is an exercise in health care 
self-management. The physician prescribes the birth control method, but with short-acting 
reversible contraceptives, the individual woman must implement its use. Our study suggests 
that provider awareness of women’s reproductive plan and sociocultural contexts of her life are 
essential to helping her select and remain adherent to an effective form of birth control. 
Additional research on locus of control and self-efficacy with dual method contraception in the 
setting of HIV, utilizing a validated measure such as Perceived Medical Condition Self-
Management Scale (PMCSMS) would likely offer additional insight into contraceptive choices 
and pregnancy spacing.  
The limitations of the analysis include those inherent in single-encounter semi-
structured interview research—understanding is emergent, so questions that arise in later 
interviews cannot be readdressed to participants who completed their interviews. Similarly, 
one cannot re-interview women to assess whether they agree with the conclusions we reached. 
In addition, some women answered at length while others provided terse responses. Therefore, 
our analysis is more heavily weighted to responses from the former group.  
Our analysis is limited by the small sample of women from a single, inner city hospital 
from a single geographical area. This said, our findings are likely generalizable to the many of 
women living with HIV in urban areas of the US. Due to the recruitment environment of a 
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single hospital program, sensitive nature of HIV, and privacy considerations embedded in the 
consent agreement with participants (e.g., the risk that the narrative of one participant who only 
agreed to participate individually might be identifiable to another participant), there was no 
formal member-checking (i.e., explicit validation of themes or conclusions drawn in this report 
by participants). Lastly, participants’ responses regarding their contraceptive experiences over 
a lifetime are affected by recall bias. Several women alluded to the influence of HIV on their 
contraceptive choices, however none clearly differentiated between practices before and after 
diagnosis. We did not enquire about differences in contraceptive practices before and after HIV 
diagnosis directly, a further limitation.  
 
Implications of Our Research for Clinical Practice, Policy, and Further Research 
 
Our study demonstrates that inner city, women living with HIV of childbearing age 
may not have an articulable understanding of the precautions they need to take to protect their 
sexual and reproductive health, that of their sexual partners, or of the implications for future 
pregnancies. Practitioners should take great care to make sure patients living with HIV have a 
comprehensive understanding of the contraceptive and reproductive health recommendations 
for planned pregnancy/pregnancy prevention and prevention of HIV and STIs. From our 
participants’ accounts, instruction at home was seen as primary, though the variability in home 
situations was also pointed up as a problem in transmission of knowledge about reproductive 
health behaviors after HIV. There is an unmet need for additional and improved reproductive 
health education for women particularly among at-risk underserved urban populations both in 
schools from early years and through Public Health programming such as wide-reaching social 
marketing campaigns. 
Beyond patients’ understanding, practitioners may want to consider the issue of trust 
and credibility in how their patients will put recommendations into practice. Our participants 
demonstrated the power that perspectives and anecdotal information coming from their 
communities had on their behavior. This trust gap suggests that practitioners reflect on what 
they do to build relationships with their patients. Our participants with HIV showed us that, 
even though they came to our clinic faithfully, they did not necessarily believe or act on our 
recommendations for health-preserving reproductive activity.  
Clinicians may also want to recognize and address the equivocal nature of 
contraception: that it brings a desired goal (healthy child spacing, prevention of disease 
transmission) on the back of practice that creates burden. Many of our participants did not feel 
well as a result of using long-acting reversible contraceptives. Use of long-acting reversible 
contraception often caused discouraging body changes such as hair loss and weight gain. 
Adherence to short and long-acting reversible contraceptives required discipline in terms of 
remembering to take pills and make arrangements (scheduling, transportation, etc.) for clinic 
appointments. Use of condoms to prevent disease transmission also interfere with the natural 
flow of sexual relations and, in the case of a woman with HIV, bring her back to the conscious 
realization of her status, a memory she may prefer to avoid. Addressing the burden of 
maintaining healthy reproductive practices after HIV may require more support than can be 
provided in typical clinic visits. At the policy level, clinics may consider how they might 
implement more personalized inquiry and follow-up to find out how individual women are 
coping with their prescribed contraceptive regimens. 
Lastly, our study suggests that personal factors, such as internal versus external locus 
of control, may play a key role in individuals’ ability to plan to use dual method contraception 
after HIV and to adhere to the plan once in place. Further research in this area is recommended. 
The women living with HIV who participated in our study viewed dual method 
contraception favorably. However, these women also discussed significant barriers to 
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contraceptive adherence, including side effects, lack of partner cooperation, and perceived risk 
of contraceptive failure. Prevention of HIV transmission during pregnancy and to partners as 
well as the need for maternal recuperation between pregnancies were identified as motivators. 
Additional research and outreach is needed to address continued barriers to pregnancy planning 
in women living with HIV. 
 
References 
 
Chen, J. L., Phillips, K. A., Kanouse, D. E., Collins, R. L., & Miu, A. (2001). Fertility desires 
and intentions of HIV-positive men and women. Family Planning Perspectives, 33(4), 
144-165. 
Chersich, M. F., Urban, M. F., Venter, F. W., Wessels, T., Krause, A., Gray, G. E., . . . & 
Viljoen, D. L. (2006). Efavirenz use during pregnancy and for women of child-bearing 
potential. AIDS Research and Therapy, 3(1), 11. 
Cleland, J., Conde-Agudelo, A., Peterson, H., Ross, J., & Tsui, A. (2012). Contraception and 
health. The Lancet, 380(9837), 149-156. 
Conde-Agudelo, A., & Belizán, J. M. (2000). Maternal morbidity and mortality associated with 
interpregnancy interval: Cross sectional study. British Medical Journal, 321(7271), 
1255-1259. 
Finer, L. B., & Zolna, M. R. (2014). Shifts in intended and unintended pregnancies in the 
United States, 2001 – 2008. American Journal of Public Health, 104(S1), S43-S48. 
Haddad, L. B., Monsour, M., Tepper, N. K., Whiteman, M. K., Kourtis, A. P., & Jamieson, D. 
J. (2017). Trends in contraceptive use according to HIV status among privately insured 
women in the United States. American Journal of Obstetrics & Gynecology, 217(6), 
e671-676. 
Hanley, G. E., Hutcheon, J. A., Kinniburgh, B. A., & Lee, L. (2017). Interpregnancy interval 
and adverse pregnancy outcomes: An analysis of successive pregnancies. Obstetrics & 
Gynecology, 129(3), 408-415. 
Kost, K. (2013). Unintended pregnancy rates at the state level: Estimates for 2002, 2004, 2006 
and 2008. New York, NY: Guttmacher Institute. 
Massad, L. S., Evans, C. T., Wilson, T. E., Golub, E. T., Sanchez-Keeland, L., Minkoff, H., . . 
. & Watts, D. H. (2007). Contraceptive use among US women with HIV. Journal of 
Women's Health, 16(5), 657-666.  
Massad, L. S., Springer, G., Jacobson, L., Watts, H., Anastos, K., Korn, A., . . . & Minkoff, H. 
(2004). Pregnancy rates and predictors of conception, miscarriage and abortion in US 
women with HIV. Aids, 18(2), 281-286. 
Morse, J. M., Barrett, M., Mayan, M., Olson, K., & Spiers, J. (2002). Verification strategies 
for establishing reliability and validity in qualitative research. International Journal of 
Qualitative Methods, 1(2), 13-22. 
QRS International. (2015). NVivo 10© Retrieved from 
http://www.qsrinternational.com/products_nvivo.aspx.  
Raifman, J., Chetty, T., Tanser, F., Mutevedzi, T., Matthews, P., Herbst, K., . . . & 
Bärnighausen, T. (2014). Preventing unintended pregnancy and HIV transmission: 
Effects of the HIV treatment cascade on contraceptive use and choice in rural KwaZulu-
Natal. Journal of Acquired Immune Deficiency Syndromes (1999), 67(Suppl 4), S218-
S227. 
Reigeluth, C. M., & Frick, T. W. (1999). Formative research: A methodology for creating and 
improving design theories. In C. M. Reigeluth (Ed.), Instructional-design theories and 
models, Volume II: A new paradigm of instructional theory (pp. 633-651). Mahwah, 
NJ: Lawrence Erlbaum. 
Rachel Scott, Piyapa Praditpan, Patricia Tanjutco, Elizabeth Laidlaw, Regina Zopf, & Manon Schladen     1073 
Sun, M., Peipert, J. F., Zhao, Q., Wilson, T. E., Weber, K. M., Sanchez-Keeland, L., . . . & 
Cohan, D. (2012). Trends in contraceptive use among women with human 
immunodeficiency virus. Obstetrics and Gynecology, 120(4), 783-790. 
Sutton, M. Y., Patel, R., & Frazier, E. L. (2014). Unplanned pregnancies among HIV-infected 
women in care—United States. Journal of Acquired Immune Deficiency 
Syndromes, 65(3), 350-358. 
Trochim, W. M. K., & Donnelly, J. P. (Eds.). (2008). The research methods knowledge base 
(3rd ed.). United States: Atomic Dog, CENGAGE Learning. 
 Tufford, L., & Newman, P. (2010). Bracketing in qualitative research. Qualitative Social 
Work, 11(1), 80-96. 
Wallston, K. A., Osborn, C. Y., Wagner, L. J., & Hilker, K. A. (2011). The perceived medical 
condition self-management scale applied to persons with HIV/AIDS. Journal of Health 
Psychology, 16(1), 109-115. 
Wilcher, R., & Cates, W. (2009). Reproductive choices for women with HIV. Bulletin of the 
World Health Organization, 87(11), 833-839. 
Wilson, T. E., Koenig, L. J., Walter, E., Fernandez, I., & Ethier, K. (2003). Dual contraceptive 
method use for pregnancy and disease prevention among HIV-infected and HIV-
uninfected women: The importance of an event-level focus for promoting safer sexual 
behaviors. Sexually Transmitted Diseases, 30(11), 809-812. 
World Health Organization. (2005). The World Health Report 2005: Make every mother and 
child count. World Health Organization. Retrieved from 
http://www.who.int/whr/2005/en/ 
World Health Organization. Reproductive Health. (2015). Medical eligibility criteria for 
contraceptive use. World Health Organization. Retrieved from 
http://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-
MEC-5/en/ 
Zhu, B. P. (2005). Effect of interpregnancy interval on birth outcomes: Findings from three 
recent US studies. International Journal of Gynecology & Obstetrics, 89, S25-S33. 
 
Author Note 
 
Rachel K. Scott, MD, MPH, is with MedStar Health Research Institute, Washington, 
D.C. and the Department of Women’s and Infants’ Services at MedStar Washington Hospital 
Center, Washington, D.C. Correspondence regarding this article can be addressed directly to: 
rachelkscott@gmail.com. 
Piyapa Praditpan, MD, MPH, is with the Department of Obstetrics and Gynecology, 
NYU Langone Medical Center, NYU School of Medicine; Brooklyn, New York. 
Correspondence regarding this article can also be addressed directly to: 
piyapa.praditpan@nyumc.org. 
Patricia Tanjutco, MD, is with MedStar Health Research Institute, Washington, D.C. 
Elizabeth Laidlaw, PA-C, MPH, received her PA-C and MPH from George Washington 
University and was an MPH student at the time of this study, Washington, D.C. 
Regina Zopf, MD, is an assistant professor with George Washington University School 
of Medicine, Washington, D.C. 
Manon Maitland Schladen, EdS, PhD, is with MedStar Health Research Institute, 
Washington, D.C. and Georgetown University Medical Center, Washington, D.C. 
Correspondence regarding this article can also be addressed directly to: 
mmschladen@gmail.com. 
This study was supported by funding from the MedStar Washington Hospital Center 
Graduate Medical Education. 
1074   The Qualitative Report 2018 
Copyright 2018: Rachel K. Scott, Piyapa Praditpan, Patricia Tanjutco, Elizabeth 
Laidlaw, Regina Zopf, Manon M. Schladen, and Nova Southeastern University. 
 
Article Citation 
 
Scott, R. K., Praditpan, P., Tanjutco, P., Laidlaw, E., Zopf, R., & Schladen, M. M. (2018). 
Barriers to pregnancy spacing in women living with HIV: A series of informational 
interviews. The Qualitative Report, 23(5), 1055-1074. Retrieved from 
https://nsuworks.nova.edu/tqr/vol23/iss5/3 
